Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism

Immunization is widely regarded as one of the most effective and beneficial tools for protecting the public's health. In the United States, immunization programs have resulted in the eradication of smallpox, the elimination of polio, and the control and near-elimination of other oncecommon, often debilitating, and potentially life-threatening diseases, including measles, mumps, rubella, diphtheria, pertussis, tetanus, and Haemophilus influenzae type b.

[1]  G. Dawson,et al.  The screening and diagnosis of autistic spectrum disorders. , 2004, Journal of autism and developmental disorders.

[2]  L. Dales,et al.  Time trends in autism and in MMR immunization coverage in California. , 2001, Journal of the American Medical Association (JAMA).

[3]  H Jick,et al.  Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis , 2001, BMJ : British Medical Journal.

[4]  E. Fombonne.  Is there an epidemic of autism? , 2001, Pediatrics.

[5]  W. Schaffner,et al.  The risk of vaccination--the importance of "negative" studies. , 2001, The New England journal of medicine.

[6]  L. Cooper.  MMR vaccine and autism: Interim comment from the AAP Executive Committee , 2001 .

[7]  W. Fraser,et al.  A Negative Search for a Paramyxoviral Etiology of Paget's Disease of Bone: Molecular, Immunological, and Ultrastructural Studies in U.K. Patients , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  S. Montgomery,et al.  Measles, mumps, rubella vaccine: through a glass, darkly. , 2000, Adverse drug reactions and toxicological reviews.

[9]  E. Maibach,et al.  Do Parents Understand Immunizations? A National Telephone Survey , 2000, Pediatrics.

[10]  P. Minor,et al.  Further evidence of the absence of measles virus genome sequence in full thickness intestinal specimens from patients with Crohn's disease , 2000, Journal of medical virology.

[11]  J. Clayton-Smith,et al.  Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males , 2000, The Lancet.

[12]  A Anthony,et al.  Enterocolitis in children with developmental disorders , 2000, American Journal of Gastroenterology.

[13]  P. Tanguay.  Pervasive developmental disorders: a 10-year review. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[14]  K. Wright,et al.  Evaluation of a Neonatal Rat Model for Prediction of Mumps Virus Neurovirulence in Humans , 2000, Journal of Virology.

[15]  R. Welsh,et al.  Consequences of cross-reactive and bystander CTL responses during viral infections. , 2000, Virology.

[16]  S. Reddy,et al.  Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype. , 2000, The Journal of clinical investigation.

[17]  D. Pardoll,et al.  Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. , 1999, Immunity.

[18]  S. Montgomery,et al.  Autism, viral infection and measles-mumps-rubella vaccination. , 1999, The Israel Medical Association journal : IMAJ.

[19]  G. Evans,et al.  Vaccine injury compensation programs worldwide. , 1999, Vaccine.

[20]  S. Nates,et al.  Measles antibody in pregnant Argentinian women relative to vaccine-induced immunity and natural infection. , 1999, The Pediatric infectious disease journal.

[21]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[22]  G. Roberts.  MMR vaccination and autism , 1999, The Lancet.

[23]  W. Bellini,et al.  Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  M. Salive,et al.  An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group. , 1999, Vaccine.

[25]  E. Fombonne,et al.  The epidemiology of autism: a review , 1999, Psychological Medicine.

[26]  Jun Li,et al.  Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association , 1999, The Lancet.

[27]  C. Gillberg,et al.  Autism: not an extremely rare disorder , 1999, Acta psychiatrica Scandinavica.

[28]  M. Zatz,et al.  Rett syndrome in a boy with a 47,XXY karyotype. , 1999, American journal of human genetics.

[29]  R. Pounder,et al.  Crohn's disease: the case for measles virus. , 1999, Italian journal of gastroenterology and hepatology.

[30]  C. Karp.  Measles: immunosuppression, interleukin‐12. and complement receptors , 1999, Immunological reviews.

[31]  Lalit,et al.  Etiology of infantile autism: a review of recent advances in genetic and neurobiological research. , 1999, Journal of psychiatry & neuroscience : JPN.

[32]  G. Schwartz,et al.  Viral teratogenesis: brain developmental damage associated with maturation state at time of infection. , 1999, Brain research. Developmental brain research.

[33]  S. Choo,et al.  Pediatric combination vaccines. , 1999, Current opinion in pediatrics.

[34]  S. Lucas,et al.  Distribution of measles virus in the central nervous system of HIV-seropositive children , 1998, Acta Neuropathologica.

[35]  S. Varga,et al.  Protective Heterologous Antiviral Immunity and Enhanced Immunopathogenesis Mediated by Memory T Cell Populations , 1998, The Journal of experimental medicine.

[36]  Christopher Gillberg,et al.  Chromosomal Disorders and Autism , 1998, Journal of autism and developmental disorders.

[37]  S. Rubin,et al.  Comparison of the Neurovirulence of a Vaccine and a Wild-Type Mumps Virus Strain in the Developing Rat Brain , 1998, Journal of Virology.

[38]  R. Pounder,et al.  Measles virus RNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcription followed by the polymerase chain reaction , 1998, Journal of medical virology.

[39]  T. Kemper,et al.  Neuropathology of infantile autism , 1998, Molecular Psychiatry.

[40]  A. Ferguson,et al.  Absence of detectable measles virus genome sequence in inflammatory bowel disease tissues and peripheral blood lymphocytes , 1998, Journal of medical virology.

[41]  D. Thomas,et al.  Rates of first measles-mumps-rubella immunisation in Wales (UK) , 1998, The Lancet.

[42]  P. Rhodes,et al.  The interruption of transmission of indigenous measles in the United States during 1993. , 1998, The Pediatric infectious disease journal.

[43]  P. Dowrick,et al.  Symptoms of pervasive developmental disorders as observed in prediagnostic home videos of infants and toddlers. , 1998, The Journal of pediatrics.

[44]  E. Miller,et al.  Impact of anti-vaccine movements on pertussis control: the untold story , 1998, The Lancet.

[45]  H. Hotta,et al.  Detection of Measles Virus mRNA from Autopsied Human Tissues , 1998, Journal of Clinical Microbiology.

[46]  S. Ellenberg,et al.  Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994. , 1997, The Journal of pediatrics.

[47]  R. Kennedy,et al.  Nonhuman primate models to evaluate vaccine safety and immunogenicity. , 1997, Vaccine.

[48]  R. Tuchman,et al.  Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. , 1997, Pediatrics.

[49]  P. Daszak,et al.  Crohn's disease after in-utero measles virus exposure , 1996, The Lancet.

[50]  H. Kraemer,et al.  State of the science in autism: Report to the National institutes of health , 1996, Journal of autism and developmental disorders.

[51]  J. Bachevalier.  Brief report: Medial temporal lobe and autism: A putative animal model in primates , 1996, Journal of autism and developmental disorders.

[52]  J. Piven,et al.  Diagnosis, treatment, and neurobiology of autism in children. , 1995, Current opinion in pediatrics.

[53]  R. Pounder,et al.  Perinatal and childhood risk factors for inflammatory bowel disease: a case-control study. , 1995, European journal of gastroenterology & hepatology.

[54]  B. P. Lewis,et al.  Overview—Combination Vaccines and Simultaneous Administration: Past, Present, and Future , 1995, Annals of the New York Academy of Sciences.

[55]  R. Insel.  Potential Alterations in Immunogenicity by Combining or Simultaneously Administering Vaccine Components a , 1995, Annals of the New York Academy of Sciences.

[56]  R. Pounder,et al.  Persistent measles virus infection of the intestine: confirmation by immunogold electron microscopy. , 1995, Gut.

[57]  C. Gillberg.  ENDOGENOUS OPIOIDS AND OPIATE ANTAGONISTS IN AUTISM: BRIEF REVIEW OF EMPIRICAL FINDINGS AND IMPLICATIONS FOR CLINICIANS , 1995, Developmental medicine and child neurology.

[58]  A. Bailey,et al.  Autism as a strongly genetic disorder: evidence from a British twin study , 1995, Psychological Medicine.

[59]  D. Griffin,et al.  Pathogenesis of measles virus infection: an hypothesis for altered immune responses. , 1994, The Journal of infectious diseases.

[60]  A. Bailey,et al.  Autism and known medical conditions: myth and substance. , 1994, Journal of child psychology and psychiatry, and allied disciplines.

[61]  M. Ernst,et al.  Naltrexone in autistic children: behavioral symptoms and attentional learning. , 1993, Journal of the American Academy of Child and Adolescent Psychiatry.

[62]  J. Stephenson,et al.  Evidence of persistent measles virus infection in Crohn's disease , 1993, Journal of medical virology.

[63]  C. Farrington,et al.  The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989. , 1992, International journal of epidemiology.

[64]  M. Leboyer,et al.  Brief report: A double-blind study of naltrexone in infantile autism , 1992, Journal of autism and developmental disorders.

[65]  S. Rubin,et al.  Borna disease: association with a maturation defect in the cellular immune response , 1991, Journal of virology.

[66]  C. Gillberg,et al.  Is Autism More Common Now than Ten Years Ago? , 1991, British Journal of Psychiatry.

[67]  S. Rogers,et al.  Age of symptom onset in young children with pervasive developmental disorders. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.

[68]  B J Freeman,et al.  The UCLA-University of Utah Epidemiologic Survey of Autism: Genealogical Analysis of Familial , 1990 .

[69]  A. Chicz–DeMet,et al.  Opioid Peptides and Perinatal Development: Is Beta‐Endorphin a Natural Teratogen? , 1990, Annals of the New York Academy of Sciences.

[70]  C. Leclerc,et al.  Carrier-induced epitopic suppression is initiated through clonal dominance. , 1989, Journal of immunology.

[71]  W. McMahon,et al.  The UCLA-University of Utah epidemiologic survey of autism: prevalence. , 1989, The American journal of psychiatry.

[72]  W. Fisher,et al.  A prevalence study of pervasive developmental disorders in North Dakota. , 1987, Journal of the American Academy of Child and Adolescent Psychiatry.

[73]  J. Panksepp,et al.  Brain opioids and autism: An updated analysis of possible linkages , 1987, Journal of autism and developmental disorders.

[74]  R. Johnson,et al.  The pathogenesis of acute viral encephalitis and postinfectious encephalomyelitis. , 1987, The Journal of infectious diseases.

[75]  K. Kumar.  Paget's disease of bone. , 1986, Calcified tissue international.

[76]  A R Hinman,et al.  Health impact of measles vaccination in the United States. , 1985, Pediatrics.

[77]  H. Itabashi,et al.  Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosing panencephalitis. , 1969, The New England journal of medicine.

[78]  I. Allen,et al.  Measles-virus antibody and antigen in subacute sclerosing panencephalitis. , 1967, Lancet.

[79]  J. G. Lewis,et al.  Screening and Diagnosis , 1964 .

[80]  T. Kemper,et al.  NEUROANATOMICAL OBSERVATIONS OF THE BRAIN IN AUTISM , 2003 .

[81]  C. Rabourdin-Combe,et al.  Mechanism of measles virus-induced suppression of inflammatory immune responses. , 2001, Immunity.

[82]  National, state, and urban area vaccination coverage levels among children aged 19-35 months--United States, 1999. , 2000, MMWR. Morbidity and mortality weekly report.

[83]  Dallas,et al.  Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2000, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[84]  G. Schild,et al.  Clinical safety issues of measles, mumps and rubella vaccines. , 2000, Bulletin of the World Health Organization.

[85]  E. Klonowski,et al.  The patient with Crohn's disease. , 1999, RN.

[86]  J. P. Davis,et al.  Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1998, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[87]  T. Matsuishi,et al.  CSF beta-endorphin levels in patients with infantile autism. , 1997, Journal of autism and developmental disorders.

[88]  S. M. Hewitt.  Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC. , 1997, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[89]  J. Parisi,et al.  Developmental disorders. , 1997, Current opinion in neurology.

[90]  Progress toward global measles control and elimination, 1990-1996. , 1997, MMWR. Morbidity and mortality weekly report.

[91]  Ann Bostrom,et al.  Vaccine Risk Communication: Lessons from Risk Perception, Decision Making and Environmental Risk Communication Research , 1997 .

[92]  S S Ellenberg,et al.  The complicated task of monitoring vaccine safety. , 1997, Public health reports.

[93]  U. Liebert.  Measles virus infections of the central nervous system. , 1997, Intervirology.

[94]  Measles Outbreak.  Measles outbreak among school-aged children--Juneau, Alaska, 1996. , 1996, MMWR. Morbidity and mortality weekly report.

[95]  R. Johnston,et al.  Options for Poliomyelitis Vaccination in the United States , 1996 .

[96]  T. Wild,et al.  Passively administered antibody suppresses the induction of measles virus antibodies by vaccinia-measles recombinant viruses. , 1995, Vaccine.

[97]  D. Nalin.  Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality , 1994, The Yale Journal of Biology and Medicine.

[98]  R. Johnston,et al.  DPT Vaccine and Chronic Nervous System Dysfunction: A New Analysis , 1994 .

[99]  V. ter meulen,et al.  Measles virus-induced autoimmune reactions against brain antigen. , 1993, Intervirology.

[100]  P E Fine,et al.  Herd immunity: history, theory, practice. , 1993, Epidemiologic reviews.

[101]  S. Redd,et al.  Measles surveillance--United States, 1991. , 1992, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[102]  R. Glück,et al.  Interference between strains in live virus vaccines, I: Combined vaccination with measles, mumps and rubella vaccine. , 1988, Journal of biological standardization.

[103]  M. Campbell,et al.  Naltrexone in infantile autism. , 1988, Psychopharmacology bulletin.

[104]  J. Peetermans,et al.  Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine. , 1986, Developments in biological standardization.

[105]  S. Marcus.  Rubella vaccination. , 1972, British medical journal.

[106]  I. Leodolter.  [Crohn's disease]. , 1967, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete.